Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease.

Autor: Perumalsamy S; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia., Huri HZ; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia., Abdullah BM; Department of Medical Laboratories Techniques, Al-Rafidain University College, Baghdad 46036, Iraq., Mazlan O; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia., Wan Ahmad WA; Cardiology Unit, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia., Vethakkan SRDB; Endocrinology Unit, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia.

Publikováno v: Metabolites [Metabolites] 2023 Mar 14; Vol. 13 (3). Date of Electronic Publication: 2023 Mar 14.

Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer.

Autor: Perumalsamy S; Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Aqilah Mohd Zin NA; Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Widodo RT; Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Wan Ahmad WA; Cardiology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Vethakkan SRDB; Endocrinology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Huri HZ; Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Publikováno v: Current pharmaceutical design [Curr Pharm Des] 2017; Vol. 23 (25), pp. 3689-3698.